Dr. Michael William Shaw Moore III, MD

Dr. Moore practices at Houston Premier Surgery Center in the Villages - HOPD in Houston, Texas.

Dr. Moore's NPI, 1508151481, was assigned on June 18, 2011. Dr. Moore graduated from McGovern Medical School in 2011. Dr. Moore holds Texas license Q6968.

Dr. Moore's primary practice is Houston Premier Surgery Center in the Villages - HOPD, at 8731 Katy Fwy, Houston, TX 77024.

Dr. Moore's primary practice is Houston Premier Surgery Center in the Villages - HOPD in Houston, Texas. Dr. Moore is also affiliated with Memorial Hermann Memorial City Medical Center. The medical group on file is Texas ENT Specialists. Dmand AI also links Dr. Moore to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Moore is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Moore's licenses on file in 2 states: Texas and South Carolina.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Moore treats.

CMS data shows 3,935 Medicare services from Dr. Moore across 25 procedure codes in 2024, for 475 Medicare patients. Medicare paid $221,251 for them. Every service was in an office.

CMS counts 475 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 235 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 54, with 51% women.

In 2024, Dr. Moore wrote 1,369 Medicare Part D claims for 401 patients. 94% of them were for generic drugs. CMS names the drug for 1,222 of them, across 25 drugs with 11 or more claims each, at $26,424 in total drug cost. In 2023, CMS named 1,030 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Moore for performance year 2024, reported as part of a group. Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Moore, published from 2010 to 2017. 2011 was the busiest year, with 2. The most frequent topics are Cochlea and Temporal Bone. Dr. Moore's most frequent co-authors are Floyd Christopher Holsinger, MD, David G. Grant, MD and Jonathan Leo Hatch, MD.

CMS Open Payments shows 191 general payments to Dr. Moore from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Acclarent, Inc paid the most, $2,850.

Dr. Moore graduated from McGovern Medical School in 2011.

Dr. Moore is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.